We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Justices Turn Away Solvay FCA Off-Label Marketing Case

Law360 (May 21, 2018, 5:05 PM EDT) -- The U.S. Supreme Court on Monday rejected a bid to revisit a decision tossing a whistleblower's False Claims Act case that had accused Solvay Pharmaceuticals of inducing false Medicaid claims through alleged off-label marketing and kickback schemes for three of its drugs.

The justices rejected, without explanation, the petition for a writ of certiorari filed by former Solvay sales and marketing employees John King and Tammy Drummond. The two had asked the high court to take up issues of when circumstantial evidence can be used to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.